Content about Macular edema

September 24, 2012

FDA approves Regeneron drug for macular edema

The Food and Drug Administration has approved a drug for treating a complication of a disease that results from vein blockages in the eye.

August 13, 2012

FDA approves Genentech's Lucentis for diabetic macular edema

Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

July 27, 2012

FDA panel recommends new approval for Genentech eye drug

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

April 8, 2011

Regeneron, Bayer commence phase-3 trial for diabetic macular edema treatment

Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.

February 11, 2011

Lucentis improves vision among diabetes patients in trial

Genentech, a subsidiary of Roche, reported that its eye drug helped improve vision in patients suffering from a complication caused by diabetes.

February 4, 2011

Alimera reports positive results of phase-3 study for Iluvien

A drug designed to treat an eye condition caused by diabetes may provide a long-term option for patients, according to Alimera Sciences.

August 31, 2010

FDA expedites review of Alimera's Iluvien

The Food and Drug Administration has granted priority review for a diabetic macular edema treatment....

June 6, 2010

Pfizer's Macugen may improve vision in diabetic macular edema patients

An investigational treatment for a complication of diabetes that often leads to blindness worked better...